Cellular cross talk between epicardial fat and cardiovascular risk

References

1. Paley, CA, Johnson, MI. Abdominal obesity and metabolic syndrome: exercise as medicine? BMC Sports Sci Med Rehabilitation 2018;10:1–8. https://doi.org/10.1186/s13102-018-0097-1.Search in Google Scholar PubMed PubMed Central

2. Poirier, P, Després, J. Waist circumference, visceral obesity, and cardiovascular risk. J Cardiopulm Rehabil 2003;23:161–9.10.1097/00008483-200305000-00001Search in Google Scholar PubMed

3. Lim, S, Meigs, JB. Links between ectopic fat and vascular disease in humans. Arterioscler Thromb Vasc Biol 2014;34:1820–7.10.1161/ATVBAHA.114.303035Search in Google Scholar PubMed PubMed Central

4. Lima-Martínez, MM, Blandenier, C, Iacobellis, G. Epicardial adipose tissue: more than a simple fat deposit? Endocrinol Nutr 2013;60:320–8. https://doi.org/10.1016/j.endoen.2012.08.013.Search in Google Scholar

5. Bedford, E. The story of fatty heart. A disease of Victorian times. Br Heart J 1972;34:23–8. https://doi.org/10.1136/hrt.34.1.23.Search in Google Scholar PubMed PubMed Central

6. Co, L, Arsenault, BJ. The concept of cardiometabolic risk: bridging the fields of diabetology and cardiology. Ann Med 2008;40:514–23.10.1080/07853890802004959Search in Google Scholar PubMed

7. Iacobellis, G, Ribaudo, MC, Assael, F, Vecci, E, Tiberti, C, Zappaterreno, A, et al.. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003;88:5163–8. https://doi.org/10.1210/jc.2003-030698. 14602744.Search in Google Scholar PubMed

8. Iacobellis, G, Corradi, D, Sharma, AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005;2:536–43. https://doi.org/10.1038/ncpcardio0319.Search in Google Scholar PubMed

9. Talman, AH, Psaltis, PJ, Cameron, JD, Meredith, IT, Seneviratne, SK, Wong, DTL. Epicardial adipose tissue: far more than a fat depot. 2014;4:416–29.Search in Google Scholar

10. Iacobellis, G, Malavazos, AE, Corsi, MM. Epicardial fat: from the biomolecular aspects to the clinical practice. Int J Biochem Cell Biol 2011;43:1651–4. https://doi.org/10.1016/j.biocel.2011.09.006.Search in Google Scholar PubMed

11. Ouwens, DM, Sell, H, Greulich, S, Eckel, J. The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease. J Cell Mol Med 2010;14:2223–34. https://doi.org/10.1111/j.1582-4934.2010.01141.x.Search in Google Scholar PubMed PubMed Central

12. Salazar, J, Luzardo, E, Mejías, JC, Rojas, J, Ferreira, A, Rivas-Ríos, JR, et al.. Epicardial fat: physiological, pathological, and therapeutic implications. Cardiol Res Pract 2016;2016:1–15. https://doi.org/10.1155/2016/1291537.Search in Google Scholar PubMed PubMed Central

13. Iacobellis, G. Epicardial and pericardial fat: close, but very different. Obesity 2009;17:625–30. https://doi.org/10.1038/oby.2008.575.Search in Google Scholar PubMed

14. Marchington, JM, Mattacks, CA, Pond, CM. Adipose tissue in the mammalian heart and pericardium : structure, foetal development and biochemical properties. Comp Biochem Physiol B 1989;94:225–32. https://doi.org/10.1016/0305-0491(89)90337-4.Search in Google Scholar PubMed

15. Sacks, HS, Fain, JN. Human epicardial adipose tissue: a review. Am Heart J 2007;153:907–17. https://doi.org/10.1016/j.ahj.2007.03.019.Search in Google Scholar PubMed

16. Mazurek, T, Zhang, L, Zalewski, A, Mannion, JD, Diehl, JT, Sarov-blat, L, et al.. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003;94:2460–6. https://doi.org/10.1161/01.CIR.0000099542.57313.Search in Google Scholar

17. Bambace, C, Telesca, M, Zoico, E, Sepe, A, Olioso, D, Rossi, A, et al.. Adiponectin gene expression and adipocyte diameter: a comparison between epicardial and subcutaneous adipose tissue in men. Cardiovasc Pathol 2011;20:e153–6. https://doi.org/10.1016/j.carpath.2010.07.005.Search in Google Scholar PubMed

18. Eiras, S, Teijeira-fernández, E, Salgado-somoza, A, Couso, E, García-caballero, T, Sierra, J, et al.. Cytokine relationship between epicardial adipose tissue adipocyte size and MCP-1 expression. Cytokine 2010;51:207–12. https://doi.org/10.1016/j.cyto.2010.05.009.Search in Google Scholar PubMed

19. Caprio, M, Antelmi, A, Muscat, A, Mammi, C, Marzolla, V, Fabbri, A, et al.. Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potentials Implications for the Treatment of Metabolic Syndrome. Endocrinology 2011;125:113–25. https://doi.org/10.1210/en.2010-0674.Search in Google Scholar PubMed

20. Rabkin, SW. Epicardial fat: properties, function and relationship to obesity. Obes Rev 2007;8:253–61. https://doi.org/10.1111/j.1467-789x.2006.00293.x.Search in Google Scholar PubMed

21. Bertaso, AG, Bertol, D, Duncan, BB, Foppa, M. Epicardial fat: definition, measurements and systematic review of main outcomes. Arq Bras Cardiol 2013;101:18–28. https://doi.org/10.5935/abc.20130138.Search in Google Scholar PubMed PubMed Central

22. Gorter, PM, Lindert, ASRV, Vos, AMD, Meijs, MFL, Graaf, YVD, Doevendans, PA, et al.. Quantification of epicardial and peri-coronary fat using cardiac computed tomography ; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis 2008;197:896–903. https://doi.org/10.1016/j.atherosclerosis.2007.08.016.Search in Google Scholar PubMed

23. Sommer, G, Garten, A, Petzold, S, Beck-Sickinger, AG, Blüher, M, Stumvoll, M, et al.. Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci 2008;115:13–23. https://doi.org/10.1042/cs20070226.Search in Google Scholar PubMed

24. Burgeiro, A, Fuhrmann, A, Cherian, S, Espinoza, D, Jarak, I, Carvalho, RA, et al.. Glucose uptake and lipid metabolism are impaired in epicardial adipose tissue from heart failure patients with or without diabetes. Am J Physiol Metab 2016;310:E550–64. https://doi.org/10.1152/ajpendo.00384.2015.Search in Google Scholar PubMed PubMed Central

25. Cherian, S, Lopaschuk, GD, Carvalho, E. Cellular cross-talk between epicardial adipose tissue and myocardium in relation to the pathogenesis of cardiovascular disease. Am J Physiol Metab 2012;303:E937–49. https://doi.org/10.1152/ajpendo.00061.2012.Search in Google Scholar PubMed

26. Guglielmi, V, Sbraccia, P. Epicardial adipose tissue: at the heart of the obesity complications. Acta Diabetol 2017;54:805–12. https://doi.org/10.1007/s00592-017-1020-z.Search in Google Scholar PubMed

27. Iacobellis, G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol 2015;11:363–71. https://doi.org/10.1038/nrendo.2015.58.Search in Google Scholar PubMed

28. Gaborit, B, Sengenes, C, Ancel, P, Jacquier, A, Dutour, A. Role of epicardial adipose tissue in health and disease: a matter of fat. Compr Physiol 2017;7:1051–82.10.1002/cphy.c160034Search in Google Scholar PubMed

29. Patel, VB, Shah, S, Verma, S, Oudit, GY. Epicardial adipose tissue as a metabolic transducer: role in heart failure and coronary artery disease. Heart Fail Rev 2017;22:889–902. https://doi.org/10.1007/s10741-017-9644-1.Search in Google Scholar PubMed

30. Wu, Y, Zhang, A, Hamilton, DJ, Deng, T. Epicardial fat in the maintenance of cardiovascular health. Methodist Debakey Cardiovasc J 2017;13:20–4. https://doi.org/10.14797/mdcj-13-1-20.Search in Google Scholar PubMed PubMed Central

31. Antonopoulos, AS, Antoniades, C. The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles. J Physiol 2017;595:3907–17. https://doi.org/10.1113/jp273049.Search in Google Scholar

32. Iacobellis, G, Willens, HJ. Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 2009;22:1311–9. https://doi.org/10.1016/j.echo.2009.10.013.Search in Google Scholar PubMed

33. Trayhurn, P. Endocrine and signalling role of adipose tissue: new perspectives on fat. Acta Physiol Scand 2005;184:285–93. https://doi.org/10.1111/j.1365-201x.2005.01468.x.Search in Google Scholar

34. Sacks, HS, Fain, JN. Human epicardial fat: what is new and what is missing? Clin Exp Pharmacol Physiol 2011;38:879–87. https://doi.org/10.1111/j.1440-1681.2011.05601.x.Search in Google Scholar PubMed

35. Iacobellis, G. Epicardial adipose tissue in endocrine and metabolic diseases. Endocrine 2014;46:8–15. https://doi.org/10.1007/s12020-013-0099-4.Search in Google Scholar PubMed

36. Galic, S, Oakhill, JS, Steinberg, GR. Adipose tissue as an enndocine organ. Mol Cell Endocrinol 2010;310:129–39. https://doi.org/10.1016/j.mce.2009.08.018.Search in Google Scholar PubMed

37. Matloch, Z, Kotulák, T, Haluzík, M. The role of epicardial adipose tissue in heart disease. Physiol Res 2016;65:23–32. https://doi.org/10.33549/physiolres.933036.Search in Google Scholar PubMed

38. Adamczak, M, Wiecek, A. The adipose tissue as an endocrine organ. Semin Nephrol 2013;33:2–13. https://doi.org/10.1016/j.semnephrol.2012.12.008.Search in Google Scholar PubMed

39. Coelho, M, Oliveira, T, Fernandes, R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci 2013;9:191–200. https://doi.org/10.5114/aoms.2013.33181.Search in Google Scholar PubMed PubMed Central

40. Bornachea, O, Vea, A, Llorente-Cortes, V. Interplay between epicardial adipose tissue, metabolic and cardiovascular diseases. Clín Invest Arterioscler 2018;30:230–9. https://doi.org/10.1016/j.arteri.2018.03.003.Search in Google Scholar PubMed

41. Christoffersen, C, Bollano, E, Lindegaard, MLS, Bartels, ED, Goetze, JP, Andersen, CB, et al.. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 2003;144:3483–90. https://doi.org/10.1210/en.2003-0242.Search in Google Scholar PubMed

42. Henrichot, E, Juge-Aubry, CE, Pernin, A, Pache, JC, Velebit, V, Dayer, JM, et al.. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 2005;25:2594–9. https://doi.org/10.1161/01.atv.0000188508.40052.35.Search in Google Scholar

43. Heather, LC, Clarke, K. Metabolism, hypoxia and the diabetic heart. J Mol Cell Cardiol 2011;50:598–605. https://doi.org/10.1016/j.yjmcc.2011.01.007.Search in Google Scholar PubMed

44. Iozzo, P. Myocardial, perivascular, and epicardial fat. Diabetes Care 2011;34:S371–9. https://doi.org/10.2337/dc11-s250.Search in Google Scholar PubMed PubMed Central

45. Cancello, R, Henegar, C, Viguerie, N, Taleb, S, Poitou, C, Rouault, C, et al.. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005;54:2277–86. https://doi.org/10.2337/diabetes.54.8.2277.Search in Google Scholar PubMed

46. Ishikawa, Y, Akasaka, Y, Ito, K, Akishima, Y, Kimura, M, Kiguchi, H, et al.. Significance of anatomical properties of myocardial bridge on atherosclerosis evolution in the left anterior descending coronary artery. Atherosclerosis 2006;186:380–9. https://doi.org/10.1016/j.atherosclerosis.2005.07.024.Search in Google Scholar PubMed

47. Ritchie, RH. Evidence for a causal role of oxidative stress in the myocardial complications of insulin resistance. Heart Lung Circ 2008;18:11–8. https://doi.org/10.1016/j.hlc.2008.11.003.Search in Google Scholar PubMed

48. Bandt, C. Statistik f ¨ur Wirtschaftswissenschaftler 2005/6. Heidelberg: Springer Gabler Berlin; 2005, 115:1111–9 pp.Search in Google Scholar

49. Navab, M, Gharavi, N, Watson, AD. Inflammation and metabolic disorders. Curr Opin Clin Nutr Metab Care 2008;11:459–64. https://doi.org/10.1097/mco.0b013e32830460c2.Search in Google Scholar

50. Rohla, M, Weiss, TW. Adipose tissue, inflammation and atherosclerosis. Clin Lipidol 2014;9:71–81. https://doi.org/10.2217/clp.13.80.Search in Google Scholar

51. Iacobellis, G, Barbaro, G. The double role of epicardial adipose tissue as pro-and anti-inflammatory organ. Horm Metab Res 2008;40:442–5. https://doi.org/10.1055/s-2008-1062724.Search in Google Scholar PubMed

52. Kawano, J, Arora, R. The role of adiponectin in obesity, diabetes, and cardiovascular disease. J Cardiometab Syndr 2009;4:44–9. https://doi.org/10.1111/j.1559-4572.2008.00030.x.Search in Google Scholar PubMed

53. Matsuda, M, Shimomura, I. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk. Horm Mol Biol Clin Invest 2014;19:75–88. https://doi.org/10.1515/hmbci-2014-0001.Search in Google Scholar PubMed

54. Xi, W, Satoh, H, Kase, H, Suzuki, K, Hattori, Y. Stimulated HSP90 binding to eNOS and activation of the PI3-Akt pathway contribute to globular adiponectin-induced NO production: vasorelaxation in response to globular adiponectin. Biochem Biophys Res Commun 2005;332:200–5. https://doi.org/10.1016/j.bbrc.2005.04.111.Search in Google Scholar PubMed

55. Feijóo-bandín, S, Rodríguez-penas, D, García-rúa, V, Mosquera-Leal, A, Gonzalez-Juanatey, JR, Lago, F. SM gr up adipokines at the cardiovascular SM journal of endocrinology and system: role in health and disease. SM J Endocrinol Metab 2016;2:1–8.Search in Google Scholar

56. Eto, T, Kitamura, K, Kato, J. Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases. Clin Exp Pharmacol Physiol 1999;26:371–80. https://doi.org/10.1046/j.1440-1681.1999.03047.x.Search in Google Scholar PubMed

57. Keef, DK, Hume, JR, Zhong, J. Regulation of cardiac and smooth muscle Ca2+ channels (CaV1.2a, b) by protein kinases. Am J Physiol Cell Physiol 2010;281:533–59.10.1152/ajpcell.2001.281.6.C1743Search in Google Scholar PubMed

58. Shimekake, Y, Nagata, K, Ohta, S, Kambayashi, Y, Teraoka, H, Kitamura, K, et al.. Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 1995;270:4412–7. https://doi.org/10.1074/jbc.270.9.4412.Search in Google Scholar PubMed

59. Wong, HK, Cheung, TT, Cheung, BM. Adrenomedullin and cardiovascular diseases. JRSM Cardiovasc Dis 2012;1:cvd.2012.012003. https://doi.org/10.1258/cvd.2012.012003. PMID: 24175071; PMCID: PMC3738363.Search in Google Scholar PubMed PubMed Central

60. Kulshrestha, H, Gupta, V, Mishra, S, Mahdi, AA, Awasthi, S, Kumar, S. Interleukin-10 as a novel biomarker of metabolic risk factors. Diabetes Metab Syndr 2018;12:543–7. https://doi.org/10.1016/j.dsx.2018.03.019.Search in Google Scholar PubMed

61. Greulich, S, Chen, WJY, Maxhera, B, Rijzewijk, LJ, van der Meer, RW, Jonker, JT, et al.. Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies. PLoS One 2013;8:e59697. https://doi.org/10.1371/journal.pone.0059697.Search in Google Scholar PubMed PubMed Central

62. Baker, AR, Harte, AL, Howell, N, Pritlove, DC, Ranasinghe, AM, Da Silva, NF, et al.. Epicardial adipose tissue as a source of nuclear factor-κB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab 2009;94:261–7. https://doi.org/10.1210/jc.2007-2579.Search in Google Scholar PubMed

63. Baroja-Mazo, A, Martín-Sánchez, F, Gomez, AI, Martínez, CM, Amores-Iniesta, J, Compan, V, et al.. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol 2014;15:738–48. https://doi.org/10.1038/ni.2919.Search in Google Scholar PubMed

64. Dutour, A, Achard, V, Sell, H, Naour, N, Collart, F, Gaborit, B, et al.. Secretory type II phospholipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease. J Clin Endocrinol Metab 2010;95:963–7. https://doi.org/10.1210/jc.2009-1222.Search in Google Scholar PubMed

65. Salgado-Somoza, A, Teijeira-Fernández, E, Fernández, ÁL, González-Juanatey, JR, Eiras, S. Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress. Am J Physiol Cell Physiol 2010;299:H202–9. https://doi.org/10.1152/ajpheart.00120.2010.Search in Google Scholar PubMed

66. Bouloumié, A, Marumo, T, Lafontan, M, Busse, R. Leptin induces oxidative stress in human endothelial cells. Faseb J 2018;13:1231–8. https://doi.org/10.1096/fasebj.13.10.1231.Search in Google Scholar

67. Prescott, MF, McBride, CK, Court, M. Develoment of intimal lesions after leukocyte migration into the vascular wall. Am J Pathol 1989;135:835–46. PMC1880112.Search in Google Scholar

68. Berg, AH, Scherer, PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939–49 pp.10.1161/01.RES.0000163635.62927.34Search in Google Scholar PubMed

69. Faria, APD, Modolo, R, Fontana, V, Moreno, H. Adipokines: novel players in resistant hypertension. J Clin Hypertens (Greenwich) 2014;16:754–9. https://doi.org/10.1111/jch.12399.Search in Google Scholar PubMed PubMed Central

70. Berg, G, Miksztowicz, V, Morales, C, Barchuk, M. Epicardial adipose tissue in cardiovascular disease. Adv Exp Med Biol 2019;1127:131–43.10.1007/978-3-030-11488-6_9Search in Google Scholar PubMed

71. Lee, SE, Kim, H-S. Human resistin in cardiovascular disease. J Smooth Muscle Res 2012;48:27–35. https://doi.org/10.1540/jsmr.48.27.Search in Google Scholar PubMed

72. Romacho, T, Sánchez-Ferrer, CF, Peiró, C. Visfatin/nampt: an adipokine with cardiovascular impact. Mediat Inflamm 2013;2013:1–15. https://doi.org/10.1155/2013/946427.Search in Google Scholar PubMed PubMed Central

73. Venteclef, N, Guglielmi, V, Balse, E, Gaborit, B, Cotillard, A, Atassi, F, et al.. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J 2015;36:795–805. https://doi.org/10.1093/eurheartj/eht099.Search in Google Scholar PubMed

74. Werner, S, Alzheimer, C. Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev 2006;17:157–71. https://doi.org/10.1016/j.cytogfr.2006.01.001.Search in Google Scholar PubMed

75. Rodríguez, JM, Wolfrum, S, Robblee, M, Chen, KY, Gilbert, ZN, Choi, JH, et al.. Altered expression of raet1e, a major histocompatibility complex class 1-like molecule, underlies the atherosclerosis modifier locus Ath11 10b. Circ Res 2013;113:1054–64. https://doi.org/10.1161/circresaha.113.302052.Search in Google Scholar

76. Sicari, R, Sironi, AM, Petz, R, Frassi, F, Chubuchny, V, Marchi, DD, et al.. Pericardial rather than epicardial fat is a cardiometabolic risk marker: an MRI vs echo study. J Am Soc Echocardiogr 2011;24:1156–62. https://doi.org/10.1016/j.echo.2011.06.013.Search in Google Scholar PubMed

77. Article, O. Epicardial fat and its association with cardiovascular risk: a cross-sectional observational study. Heart Views 1995;11:103–8.10.4103/1995-705X.76801Search in Google Scholar

78. Doesch, C, Haghi, D, Flüchter, S, Suselbeck, T, Schoenberg, S, Michaely, H, et al.. Epicardial adipose tissue in patients with heart failure. J Cardiovasc Magn Reson 2010;12:40–50. https://doi.org/10.1186/1532-429x-12-40.Search in Google Scholar

79. Iacobellis, G, Assael, F, Ribaudo, MC, Zappaterreno, A, Alessi, G, Mario, UD, et al.. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 2003;11:0–6. https://doi.org/10.1038/oby.2003.45.Search in Google Scholar PubMed

80. Saura, D, Oliva, MJ, Rodríguez, D, Pascual-figal, DA, Hurtado, JA, Pinar, E, et al.. Reproducibility of echocardiographic measurements of epicardial fat thickness. Int J Cardiol 2010;141:311–3. https://doi.org/10.1016/j.ijcard.2008.11.127.Search in Google Scholar PubMed

81. Nelson, AJ, Worthley, MI, Psaltis, PJ, Carbone, A, Dundon, BK, Duncan, RF, et al.. Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume. J Cardiovasc Magn Reson 2009;8:1–8.10.1186/1532-429X-11-15Search in Google Scholar PubMed PubMed Central

82. Sarin, S, Wenger, C, Marwaha, A, Qureshi, A, Go, BDM, Woomert, CA, et al.. Clinical significance of epicardial fat measured using cardiac multislice computed tomography. Am J Cardiol 2008. https://doi.org/10.1016/j.amjcard.2008.04.058.Search in Google Scholar PubMed

83. Forouzandeh, F, Chang, SM, Muhyieddeen, K, Zaid, RR, Trevino, AR, Xu, J, et al.. Does quantifying epicardial and intrathoracic fat with noncontrast computed tomography improve risk stratification beyond calcium scoring alone? Circ Cardiovasc Imaging 2012;6:58–67. https://doi.org/10.1161/CIRCIMAGING.112.976316.Search in Google Scholar PubMed

84. Iacobellis, G, Leonetti, F. Epicardial adipose tissue and insulin resistance in in obese subjects. J Clin Endocrinol Metab 2015;90:6300–2. https://doi.org/10.1210/jc.2005-1087.Search in Google Scholar PubMed

85. Nelson, MR, Mookadam, F, Thota, V, Emani, U, Harthi, MA, Lester, SJ, et al.. Epicardial fat: an additional measurement for subclinical atherosclerosis and cardiovascular risk stratification. J Am Soc Echocardiogr 2011;24:339–45. https://doi.org/10.1016/j.echo.2010.11.008.Search in Google Scholar PubMed

86. Alexopoulos, N, Lean, DSM, Janik, M, Arepalli, CD, Stillman, AE, Raggi, P. Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis 2010;210:150–4. https://doi.org/10.1016/j.atherosclerosis.2009.11.020.Search in Google Scholar PubMed

87. Shmilovich, H, Dey, D, Cheng, VY, Rajani, R, Nakazato, R, Otaki, Y, et al.. Threshold for the upper normal limit of indexed epicardial fat volume: derivation in a healthy population and validation in an outcome-based study. Am J Cardiol 2011;108:1680–5. https://doi.org/10.1016/j.amjcard.2011.07.031. Epub 2011 Aug 30. PMID: 21880291; PMCID: PMC3215795.Search in Google Scholar PubMed PubMed Central

88. Salami, SS, Tucciarone, M, Bess, R, Kolluru, A, Szpunar, S, Rosman, H. Epicardial fat: the impact of a anthropometric measurements, although epicardial fat has also been shown to be associated with intra-relatively little is known about the patterns of epicardial fat in blacks compared to whites 2013;23:8–10.Search in Google Scholar

89. Nerlekar, N, Brown, AJ, Muthalaly, RG, Talman, A, Hettige, T, Cameron, JD, et al.. Association of epicardial adipose tissue and high-risk plaque characteristics: a systematic review and meta-analysis. J Am Heart Assoc 2016;6:1. https://doi.org/10.1161/JAHA.117.006379.Search in Google Scholar PubMed PubMed Central

90. Mancio, J, Azevedo, D, Saraiva, F, Azevedo, AI, Pires-morais, G, Leite-moreira, A, et al.. Epicardial adipose tissue volume assessed by computed tomography and coronary artery disease : a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging 2018;19:1–8. https://doi.org/0.1093/ehjci/jex314.10.1093/ehjci/jex314Search in Google Scholar PubMed

91. Djaberi, R, Schuijf, JD, van Werkhoven, JM, Nucifora, G, Jukema, JW, Bax, JJ. Relation of epicardial adipose tissue to coronary atherosclerosis. Am J Cardiol 2008;102:1602–7. https://doi.org/10.1016/j.amjcard.2008.08.010.Search in Google Scholar PubMed

92. Nakazato, R, Rajani, R, Cheng, VY, Shmilovich, H, Nakanishi, R, Otaki, Y, et al.. Weight change modulates epicardial fat burden: a 4-year serial study with non-contrast computed tomography. Atherosclerosis 2012;220:139–44. https://doi.org/10.1016/j.atherosclerosis.2011.10.014.Search in Google Scholar PubMed PubMed Central

93. Iacobellis, G. Epicardial fat: a new cardiovascular therapeutic target. Curr Opin Pharmacol 2016;27:13–8. https://doi.org/10.1016/j.coph.2016.01.004.Search in Google Scholar PubMed

94. Moore, THM, Bartlett, C, Burke, MA, Smith, GD, Ebrahim, SBJ. Statins for preventing cardiovascular disease. Cochrane Database Syst Rev 2004;3.10.1002/14651858.CD004816Search in Google Scholar

95. Morano, S, Romagnoli, E, Filardi, T, Nieddu, L, Mandosi, E, Fallarino, M, et al.. Short-term effects of glucagon-like peptide 1 (GLP-1) receptor agonists on fat distribution in patients with type 2 diabetes mellitus: an ultrasonography study. Acta Diabetol 2015;52:727–32. https://doi.org/10.1007/s00592-014-0710-z.Search in Google Scholar PubMed

96. Marques, AP, Cunha-Santos, J, Leal, H, Sousa-Ferreira, L, Pereira de Almeida, L, Cavadas, C, et al.. Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice. Biochim Biophys Acta Gen Subj 2018;1862:403–13. https://doi.org/10.1016/j.bbagen.2017.11.012.Search in Google Scholar PubMed

97. Lima-Martínez, MM, Paoli, M, Rodney, M, Balladares, N, Contreras, M, D’Marco, L, et al.. Effect of sitagliptin on epicardial fat thickness in subjects with type 2 diabetes and obesity: a pilot study. Endocrine 2016;51:448–55. https://doi.org/10.1007/s12020-015-0710-y.Search in Google Scholar PubMed

98. Adams, M, Montague, CT, Prins, JB, Holder, JC, Smith, SA, Sanders, L, et al.. Activators of peroxisome proliferator-activated receptor γ have depot- specific effects on human preadipocyte differentiation. J Clin Invest 1997;100:3149–53. https://doi.org/10.1172/jci119870.Search in Google Scholar